IIntegra Therapeutics
Barcelona-based biotech developing next-generation gene writing tools for advanced therapies, including its flagship FiCAT platform combining CRISPR-Cas precision with engineered piggyBac transposase gene-transfer efficiency. Founded in 2020 as a spin-off of Universitat Pompeu Fabra (UPF), it targets gene therapies for rare diseases and cell therapies (e.g. CAR-T) for oncology and autoimmune disease. Has raised roughly $22.9M across seed and pre-Series A rounds, most recently a €10.7M round in September/October 2025.
SectorsGene Editing, Gene Therapy, Cell Therapy, Biotechnology
Start-up MapHealthtech & Bio › Drug discovery & therapeutics developers
Founders
A
Avencia Sánchez-Mejías
Co-founder & Chief Executive Officer
M
Marc Güell
Co-founder & Chief Scientific Officer
Global models 5
TTessera Therapeutics
United States · www.tesseratx.com ↗
Gene writing platform company that uses engineered mobile-element-derived enzymes to insert or rewrite DNA for genetic medicines, the closest match to Integra's FiCAT approach.
$560MComparable
PPrime Medicine
United States · primemedicine.com ↗
Raised this privately before its IPO to develop prime editing, including recombinase-assisted large gene insertion, as a platform for in vivo and ex vivo therapies.
$315MComparable
MMetagenomi
United States · metagenomi.co ↗
Raised this privately before its IPO for a platform of novel CRISPR nucleases and CRISPR-associated transposases (CAST) for targeted gene insertion in genetic medicines.
$300MComparable
T
Tome Biosciences
United States
Built programmable genomic integration (PASTE), which pairs CRISPR targeting with integrase-mediated insertion of whole genes, a close technical analogue of FiCAT; it wound down in 2024.
$213MComparable
S
SalioGen Therapeutics
United States · www.saliogen.com ↗
Develops 'Gene Coding' therapies with an engineered mammalian transposase platform for non-viral insertion of whole genes, like Integra's piggyBac-based gene transfer.
$115MComparable
In the same niche 67 others
See all in the Start-ups Map →
Notes: Most funded first
Investors 7
Open as list →
CColumbus Venture Partners
columbusvp.com
IInvivo Partners
invivo.partners
CCentro para el Desarrollo Tecnológico y la Innovación
www.cdti.es
EEIC Fund
eic.ec.europa.eu
AAdvent France Biotechnology
AAdBio Partners
TTakeda Ventures
Funding rounds 2
·1 not counted| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-09-08 | Pre-Series A | €10.7M |
Lead not disclosed
+6 more
|
| 2021-12-02 | Seed | €6M |
Advent France Biotechnology
+4 more
|